The Chemotherapy-Induced Thrombocytopenia Market is projected to grow from USD 1,393.34 million in 2024 to USD 1,896.14 million by 2031, with a CAGR of 4.5%. The market focuses on managing low platelet counts in cancer patients undergoing chemotherapy. https://www.datamintelligence.com/research-report/chemotherapy-induced-thrombocytopenia-market